The Central Government, on the 28th of December, Tuesday, cleared two more vaccines against the Wuhan virus, also known as the Novel Coronavirus (COVID-19,) for emergency use.
According to sources, the decision was taken during a high level meeting held by the Union Health Ministry and on December 28. The decision taken during a high-level meeting was welcomed by manufacturers of the two vaccines; CORBEVAX and COVOVAX and an antiviral drug.
Mr. Mansukh Mandaviya, the Union Health Minister, took to Twitter and said, “Further strengthening the fight against Covid-19, CDSCO, health ministry has given 3 approvals in a single day for CORBEVAX vaccine, COVOVAX vaccine, anti-viral drug Molnupiravir for restricted use in an emergency situation.”
The approval comes a day after the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting emergency use authorisation for the above two vaccines and one anti-viral drug.
Covovax will be made by the Serum Institute of India (SII) while Biological-E will make the Corbevax vaccine.
Notably, CORBEVAX, manufactured by Biological E. Limited, passed two Phase III clinical trials. The trials were conducted on over 3,000 subjects, people between the age group of 18 year old to 80 year-old.
Till now, Covishield, Covaxin, Sputnik V, Moderna, Johnson and Johnson and ZyCoV-D have so far received the authorisation.
